Listas Anotadas de Medicamentos e Dispositivos
| Listas | Seção | Observação |
|---|---|---|
| PAHO Strategic Fund Medicine List | 6.1. Antihypertensive medicines | Sem observações |
| WHO Model List of Essential Medicines (2021) | 12.3. Antihypertensive medicines |
Outras observações: Therapeutic alternatives: - 4th level ATC chemical subgroup (C09CA Angiotensin II receptor blockers (ARBs), plain) (for telmisartan) - 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives) (for amlodipine) |
| Listas | Seção | Observação |
|---|---|---|
| PAHO Strategic Fund Medicine List | 6.1. Antihypertensive medicines | Sem observações |
| WHO Model List of Essential Medicines (2021) | 12.3. Antihypertensive medicines |
Outras observações: Therapeutic alternatives: - 4th level ATC chemical subgroup (C09CA Angiotensin II receptor blockers (ARBs), plain) (for telmisartan) - 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives) (for amlodipine) |
| Listas | Seção | Observação |
|---|---|---|
| PAHO Strategic Fund Medicine List | 6.1. Antihypertensive medicines | Sem observações |
| WHO Model List of Essential Medicines (2021) | 12.3. Antihypertensive medicines |
Outras observações: Therapeutic alternatives: - 4th level ATC chemical subgroup (C09CA Angiotensin II receptor blockers (ARBs), plain) (for telmisartan) - 4th level ATC chemical subgroup (C08CA Dihydropyridine derivatives) (for amlodipine) |